Cyclo Therapeutics (CYTHW) Competitors $0.23 -0.01 (-3.87%) As of 02/21/2025 03:51 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends CYTHW vs. ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, and BCTXWShould you be buying Cyclo Therapeutics stock or one of its competitors? The main competitors of Cyclo Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry. Cyclo Therapeutics vs. 180 Life Sciences 4D pharma Aardvark Therapeutics Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and Cyclo Therapeutics (NASDAQ:CYTHW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends, media sentiment, valuation and community ranking. Is ATNFW or CYTHW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Cyclo Therapeutics N/A N/A N/A Which has preferable valuation & earnings, ATNFW or CYTHW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ACyclo Therapeutics$870.73KN/AN/AN/AN/A Does the media refer more to ATNFW or CYTHW? In the previous week, 180 Life Sciences had 1 more articles in the media than Cyclo Therapeutics. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Cyclo Therapeutics. 180 Life Sciences' average media sentiment score of 1.38 beat Cyclo Therapeutics' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Positive Cyclo Therapeutics Neutral Does the MarketBeat Community prefer ATNFW or CYTHW? 180 Life Sciences and Cyclo Therapeutics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ACyclo TherapeuticsN/AN/A Summary180 Life Sciences beats Cyclo Therapeutics on 2 of the 3 factors compared between the two stocks. Get Cyclo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTHW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYTHW vs. The Competition Export to ExcelMetricCyclo TherapeuticsDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.35B$5.84B$9.15BDividend YieldN/A2.92%4.75%3.85%P/E RatioN/A4.2726.1519.13Price / SalesN/A733.09435.3370.72Price / CashN/A10.2538.0134.83Price / BookN/A7.507.644.62Net IncomeN/A$20.70B$3.19B$245.94M7 Day Performance-18.09%-0.12%-2.11%-2.62%1 Month Performance-22.74%0.00%-0.49%-2.15%1 Year Performance0.43%97.97%16.44%12.95% Cyclo Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYTHWCyclo TherapeuticsN/A$0.23-3.9%N/A-24.4%$0.00$870,725.000.009Gap DownHigh Trading VolumeATNFW180 Life SciencesN/A$0.01+6.5%N/A+51.5%$0.00N/A0.007News CoverageGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAARDAardvark TherapeuticsN/A$13.30-7.1%N/AN/A$0.00N/A0.0018Insider TradeNews CoverageHigh Trading VolumeAEHAWAesther Healthcare AcquisitionN/A$0.03-7.4%N/A-13.4%$0.00N/A0.002Gap DownAIMDWAinosN/A$0.13-0.7%N/A+138.5%$0.00$40,633.000.0040Gap UpALVOWAlvotechN/A$2.45+6.5%N/A-46.2%$0.00$391.87M0.004Gap UpACABWAtlantic Coastal Acquisition Corp. IIN/A$0.05-16.9%N/A-54.4%$0.00N/A0.004Gap UpBFRIWBiofronteraN/A$0.06flatN/A+254.1%$0.00$35.36M0.0070BTMDWbioteN/A$0.53+5.8%N/A-46.2%$0.00$193.06M0.00N/AGap UpBCTXWBriaCell TherapeuticsN/A$0.12flatN/A-92.9%$0.00N/A0.008Gap Down Related Companies and Tools Related Companies ATNFW Competitors LBPSW Competitors AARD Competitors AEHAW Competitors AIMDW Competitors ALVOW Competitors ACABW Competitors BFRIW Competitors BTMDW Competitors BCTXW Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CYTHW) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored(1) Elon Musk’s Final Project REVEALEDThe world’s richest man has an ace up his sleeve. You see, while everyone is talking about Elon Musk’s plan...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
